Screening for Obstructive Sleep Apnea in an Atrial Fibrillation Population: What's the Best Test?

Samantha Y Starkey, Daniel R Jonasson, Stephanie Alexis, Susan Su, Ravinder Johal, Paul Sweeney, Penelope M A Brasher, John Fleetham, Najib Ayas, Teddi Orenstein, Iqbal H Ahmed, Samantha Y Starkey, Daniel R Jonasson, Stephanie Alexis, Susan Su, Ravinder Johal, Paul Sweeney, Penelope M A Brasher, John Fleetham, Najib Ayas, Teddi Orenstein, Iqbal H Ahmed

Abstract

Background: Among individuals with nonvalvular atrial fibrillation (AF), the prevalence of obstructive sleep apnea (OSA) can be as high as 85%. Continuous positive airway pressure treatment for moderate or severe OSA might improve AF outcomes and quality of life, so early identification of OSA might be of value. However, screening questionnaires for OSA are suboptimal because they are weighted toward tiredness and loud snoring, which might be absent in AF patients. NoSAS (Neck, Obesity, Snoring, Age, Sex) is a new OSA questionnaire that excludes these parameters. Acoustic pharyngometry (AP) is a potential novel screening technique that measures pharyngeal cross-sectional area, which is reduced in patients with OSA.

Methods: We prospectively compared the accuracy of the NoSAS, the STOP-BANG questionnaire (Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender), and AP with home sleep apnea testing (HSAT) in consecutive patients with nonvalvular AF.

Results: Of 188 participants, 86% had OSA and 49% had moderate or severe OSA. Mean Epworth Sleepiness Scale scores were low; 5.9 (SD, 3.9), indicating that most participants were not sleepy. Receiver operating characteristic curves for comparisons of screening tests with HSAT showed suboptimal accuracy. For moderate plus severe and severe only groups respectively, the area under the curve was 0.50 (95% confidence interval [CI], 0.42-0.58) and 0.42 (95% CI, 0.34-0.52) for AP, 0.65 (95% CI, 0.58-0.73) and 0.63 (95% CI, 0.52-0.74) for the STOP-BANG questionnaire, and 0.68 (95% CI, 0.60-0.75) and 0.69 (95% CI, 0.59-0.80) for the NoSAS.

Conclusions: AP and NoSAS are not sufficiently accurate for screening AF patients for OSA. Because of the high rates of OSA in this cohort, the potential benefits of OSA treatment, and the suboptimal accuracy of current screening questionnaires, cardiologists should consider HSAT for AF patients.

© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.

Figures

Figure 1
Figure 1
Patient participation in the study. AF, atrial fibrillation.
Figure 2
Figure 2
Study flow diagram. ESS, Epworth Sleepiness Scale; HSAT, home sleep apnea test; NoSAS, NoSAS (Neck, Obesity, Snoring, Age, Sex) questionnaire; SBQ, STOP-BANG (Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender) questionnaire.
Figure 3
Figure 3
(Left) A demonstration of the acoustic pharyngometry technique. (Right) Graph generated from acoustic pharyngometry. The reflected acoustic waves create a curve of distance from the mouthpiece (x-axis) against cross-sectional area (y-axis) from which the positions of various oropharyngeal structures can be identified. Reproduced from Gelardi et al. with permission from lead author and under the Creative Commons Attribution 4.0 International Public License.
Figure 4
Figure 4
Receiver operating characteristic curves for NoSAS Questionnaire (Neck, Obesity, Snoring, Age, Sex), STOP-BANG (Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender) questionnaire (SBQ), minimal circumferential area of the oropharynx (MCA), and Epworth Sleepiness Scale (ESS) compared with home sleep apnea test. Red indicates moderate and severe obstructive sleep apnea (apnea-hypopnea index ≥ 15); blue indicates severe obstructive sleep apnea (apnea-hypopnea index ≥ 30). For area under the curve values, see Table 3.

References

    1. Traaen G.M., Øverland B., Aakerøy L. Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation. Int J Cardiol. 2020;26:100463.
    1. Abumuamar A.M., Dorian P., Newman D., Shapiro C.M. The prevalence of obstructive sleep apnea in patients with atrial fibrillation. Clin Cardiol. 2018;41:601–607.
    1. Costa L.E., Uchôa C.H.G., Harmon R.R. Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting. Heart. 2015;101:1288–1292.
    1. Epstein L.J., Kristo D., Strollo P.J. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5:263–276.
    1. Giles T.L., Lasserson T.J., Smith B. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;3:CD001106.
    1. Desteghe L., Hendriks J.M.L., McEvoy R.D. The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation. Clin Res Cardiol. 2018;107:617–631.
    1. Maeder M.T., Schoch O.D., Rickli H. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:85–103.
    1. Linz D., McEvoy R.D., Cowie M.R. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment. JAMA Cardiol. 2018;3:532–540.
    1. Yang Y., Ning Y., Wen W. CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis. J Interv Card Electrophysiol. 2020;58:369–379.
    1. Kuhn E., Schwarz E.I., Bratton D.J., Rossi V.A., Kohler M. Effects of CPAP and mandibular advancement devices on health-related quality of life in OSA: a systematic review and meta-analysis. Chest. 2017;151:786–794.
    1. Walia H.K., Thompson N.R., Pascoe M. Effect of positive airway pressure therapy on drowsy driving in a large clinic-based obstructive sleep apnea cohort. J Clin Sleep Med. 2019;15:1613–1620.
    1. Venkataraman S., Vungarala S., Covassin N., Somers V.K. Sleep apnea, hypertension and the sympathetic nervous system in the adult population. J Clin Med. 2020;9:591.
    1. Kapur V.K., Auckley D.H., Chowdhuri S. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479–504.
    1. Collop N.A., Anderson W.M.D., Boehlecke B. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2007;3:737–747.
    1. Abumuamar A.M., Dorian P., Newman D., Shapiro C.M. The STOP-BANG questionnaire shows an insufficient specificity for detecting obstructive sleep apnea in patients with atrial fibrillation. J Sleep Res. 2018;27
    1. DeYoung P.N., Bakker J.P., Sands S.A. Acoustic pharyngometry measurement of minimal cross-sectional airway area is a significant independent predictor of moderate-to-severe obstructive sleep apnea. J Clin Sleep Med. 2013;9:1161–1164.
    1. Kamal I. Test-retest validity of acoustic pharyngometry measurements. Otolaryngol Head Neck Surg. 2004;130:223–228.
    1. Coutinho Costa J., Rebelo-Marques A., Machado J.N. Validation of NoSAS (Neck, Obesity, Snoring, Age, Sex) score as a screening tool for obstructive sleep apnea: analysis in a sleep clinic. Pulmonology. 2019;25:263–270.
    1. Marti-Soler H., Hirotsu C., Marques-Vidal P. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016;4:742–748.
    1. Altmann D.R., Ullmer E., Rickli H. Clinical impact of screening for sleep related breathing disorders in atrial fibrillation. Int J Cardiol. 2012;154:256–258.
    1. Kadhim K., Middeldorp M.E., Elliott A.D. Self-reported daytime sleepiness and sleep-disordered breathing in patients with atrial fibrillation: SNOozE-AF. Can J Cardiol. 2019;35:1457–1464.
    1. January C.T., Wann L.S., Alpert J.S. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64:e1–e76.
    1. Gelardi M., Del Giudice A., Cariti F. Acoustic pharyngometry: clinical and instrumental correlations in sleep disorders. Braz J Otorhinolaryngol. 2007;73:257–265.
    1. Berry R.B., Quan S.F., Abreu A.R. American Academy of Sleep Medicine; Darien, IL: 2020. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 2.6.
    1. Hunter J.D. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90–95.
    1. Pedregosa F., Varoquaux G., Gramfort A. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–2830.
    1. Farrehi P.M., O’Brien L.M., Bas H.D. Occult obstructive sleep apnea and clinical outcomes of radiofrequency catheter ablation in patients with atrial fibrillation. J Interv Card Electrophysiol. 2015;43:279–286.
    1. Kendzerska T., Grewal M., Ryan C.M. Utility of acoustic pharyngometry for the diagnosis of obstructive sleep apnea. Ann Am Thorac Soc. 2016;13:2019–2026.
    1. Kim B.Y., Cho J.H., Kim D.H. Utility of acoustic pharyngometry for screening of obstructive sleep apnea. Auris Nasus Larynx. 2020;47:435–442.
    1. Linz D., Kadhim K., Brooks A.G. Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients. Int J Cardiol. 2018;272:155–161.
    1. Linz D., Kalman J.M., R Doug M., Sanders P. CPAP initiation in persistent atrial fibrillation: Have we overslept the alarm clock? Int J Cardiol. 2019;278:144–146.
    1. Nigro C.A., Dibur E., Malnis S., Grandval S., Nogueira F. Validation of ApneaLink Ox for the diagnosis of obstructive sleep apnea. Sleep Breath. 2013;17:259–266.
    1. Linz D., Brooks A.G., Elliott A.D. Nightly variation in sleep apnea severity as atrial fibrillation risk. J Am Coll Cardiol. 2018;72:2406–2407.

Source: PubMed

3
Subskrybuj